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Colloidal quantum dots (QDs) are now commercially available in a biofunctionalized form, and F¨ orster resonance energy transfer
(FRET) between bioconjugated dots and ﬂuorophores within the visible range has been observed. We are particularly interested in
the far-red region, as from a biological perspective there are beneﬁts in pushing to ∼700nm to minimize optical absorption (ABS)
withintissueand toavoid cell autoﬂuorescence. We reportonFRET between streptavidin- (STV-)conjugated CdTequantumdots,
Qdot705-STV, with biotinylated DY731-Bio ﬂuorophores in a donor-acceptor assay. We also highlight the changes in DY731-Bio
absorptivity during the streptavidin-biotin binding process which can be attributed to the structural reorientation. For ﬂuores-
cence beyond 700nm, diﬀerent alloy compositions are required for the QD core and these changes directly aﬀect the ﬂuorescence
decay dynamics producing a marked biexponential decay with a long-lifetime component in excess of 100 nanoseconds. We com-
pare the inﬂuence of the two QD relaxation routes upon FRET dynamics in the presence of DY731-Bio.
Copyright © 2007 E. Z. Chong et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
F¨ orster (or ﬂuorescence) resonance energy transfer was ﬁrst
explored in the 1920s [1] and is increasingly gaining the
attention of multidisciplinary researchers. FRET is a tech-
nique widely used in probing the conformational changes of
biomolecules, examining the structural constitution of a tar-
geted cell and monitoring intracellular processes and many
other in vivo biological applications [2]. The main attraction
of FRET is its sensitivity to very small spatial changes, typi-
cally in the nanometer range.
FRET is based on the near ﬁeld interaction between two
molecules (dipoles) in very close proximity, at a distance
much smaller than the ﬂuorescence wavelength [3, 4]. The
excited state energy of the donor molecule can be trans-
ferred to the acceptor molecule in the ground state if there
is a considerable overlap between the donor emission and
the acceptor absorption. In the past, a variety of organic
ﬂuorescent labels were used as probes in FRET measure-
ments [3–5]. However, photobleaching eﬀects have impaired
their function as reliable ﬂuorescent markers especially in
single-molecule spectroscopic applications. With the discov-
ery of new robust ﬂuorescent material such as semiconduc-
torquantumdots, the possibility ofphotobleaching the inor-
ganic markers over extended excitation is no longer an issue.
QDs are well known for their photostability, high quantum
yield (QY), broad absorption spectrum, and narrow emis-
sion spectrum [6–8]. In contrast to the standard organic
dyes, these favourable features provide a new route to op-
tically pump diﬀerent size QDs using the same photoexcita-
tion energy, thus promoting multicolour microscopic imag-
ing. The speciﬁc application area which we seek to address
is in vitro cell cycle and cell lineage studies. In this context
we have conﬁrmed that there is no discernible toxic eﬀect of
core/shellQDs on the cellsover typical analysisperiod of 1–5
days which corroborates the fact that the release of free ions
from the core lattice is largely obviated by the surface passi-
vation [9]. Furthermore, with the advent of the commercial
core-shell QDs, a variety of emissions that cover the visible
and the infrared spectra are readily available. Therefore, in
view of the superior photostability, the biocompatibility and
the wide selection of commercial core/shell QDs, the poten-
tial of QDs as ﬂuorescent labels is very promising.
In this work, we explored the potential of far-red
CdTe/ZnS core-shell Qdot705 (Invitrogen) as an eﬃcient
donor in a FRET assay. From the bioimaging perspective,2 Journal of Biomedicine and Biotechnology
this avoids the detection of autoﬂuorescence, allows the us-
age of red excitation which has greater depth of penetra-
tion into targeted tissue, and facilitates multiphoton absorp-
tion/excitation. From a material point of view, the compo-
sitional change from selenide to telluride in Qdot705 also
makes it an interesting experimental test subject. Broader
emission/absorption spectra and a ﬂuorescence decay life-
time well in excess of 100 nanoseconds at room tempera-
ture were seen. In our QD FRET investigation, biotinylated
DY731-Bio ﬂuorophores with an absorption peak at 720nm
were self-assembled onto Qdot705-STVs that emit at 705nm
usingastreptavidin-biotinbindingmechanisminthesimilar
conjugation route as that in [10, 11]. Due to the strong spec-
tral overlap between Qdot705-STV emission and DY731-Bio
absorption,FRETsignaturesweredetectedinthesteadystate
and also in the time domain spectroscopic measurements.
2. MATERIALS AND METHODS
2.1. DY731-Bio-STVpreparation
1mg of streptavidin powder (Sigma-Aldrich, Dorset, UK)
was dissolved in 100μL phosphate buﬀered saline (PBS
0.01M,pH7.4)tomake ∼170μMstreptavidinsolution.5μL
of the solution was added to 400μLo f2 . 5μM DY731-Bio to
give a loading ratio of 1 with respect to DY731-Bio. As a re-
sult, the total biotin binding sites outnumbered DY731-Bio.
Hence, only streptavidin bound DY731-Bio were generated.
The steady-state absorption proﬁle of DY731-Bio-STV bio-
complex was recorded with a UV/Vis/NIR Jasco V570 spec-
trometer (Tokyo, Japan) for determining DY731-Bio-STV
molar extinction coeﬃcient.
2.2. Qdot705-STVandDY731-Biomixturebytitrations
10μLo f1μM Qdot705-STV stock (Invitrogen, Calif, USA)
wasdissolvedin400μLPBS(pH7.4)ina10mmopticalpath
cell. 2μLo f3 0 μM DY731-Bio (MoBiTec, G¨ ottingen, Ger-
many) was ﬁrst dispensed into the QD solution and then fol-
lowed by 10 successive titrations of 4μL DY731-Bio. Steady-
state photoluminescence (PL) measurements were taken af-
ter each titration using a Varian Cary Eclipse ﬂuorimeter
(Palo Alto, Calif, USA). For comparison, identical proce-
dures were repeated for control experiments which involved
DY731-Bio without the presence of Qdot705-STV.
2.3. Qdot705-STV-DY731-Bioconjugatespreparation
5 separate PBS diluted Qdot705-STV solutions (220μL,
∼90nM) were mixed with increasing amount (4μLt o
200μL) of 30μM DY731-Bio to produce Qdot705-STV-
DY731-Bio donor-acceptor assay with diﬀerent labelling ra-
tios. It is estimated that a Qdot705-STV is chemically cou-
pled to 5–10 streptavidin [12]. As streptavidin is a tetrameric
protein, approximately 20–40 biotinylated molecules which
include DY731-Bio can be arrayed around a single Qdot705-
STV. The samples were left to sit at room temperature for
15 minutes. By ultraﬁltration with Microcon YM50 spin col-
umn (Millipore, Billerica, Mass, USA), the unbound DY731-
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Figure 1: Schematic diagram of Qdot705-STV and DY731-Bio in
self-assembledassaywhereenergycanbetransferrednonradiatively
from QD to DY731-Bio upon excitation.
Bio (molecular weight, MW of ∼1kDa) were separated from
the conjugated pairs. The column with cutoﬀ MW of 50kDa
was spun at a centrifugal speed of 2000 × g three times for
20 minutes per wash. The collected conjugates were then dis-
solved in 100μL PBS in 10mm path length cuvette for time-
resolved PL measurements. The average numbers of DY731-
BioperQdot705-STVwereestimatedbysteady-stateabsorp-
tion using a UV/Vis/NIR Jasco V570 spectrometer in ac-
cordance to the molar extinction coeﬃc i e n ta t6 6 3n mf o r
DY731-Bio-STV.
2.4. Steady-stateabsorptionand
photoluminescencemeasurements
Steady-state absorptions of Qdot705-STV, DY731-Bio,
DY731-Bio-STV and Qdot705-STV-DY731-Bio in PBS
(pH 7.4) were measured using a UV/Vis/NIR Jasco V570
spectrometer. Ensemble photoluminescence spectra were
recorded with a Varian Cary Eclipse ﬂuorimeter. To mea-
sure the photoluminescence spectrum of DY731-Bio,
680nm excitation was chosen. However, the excitation
was set to 425nm for all FRET experiments in order to
reduce the direct excitation of DY731-Bio ﬂuorophores. All
measurements were performed under ambient conditions.
2.5. Time-resolvedphotoluminescencemeasurements
Qdot705-STV-DY731-Bio samples (from Section 2.3)w e r e
photoexcited using a Ti:Sapphire laser (Coherent, Santa
Clara, Calif, USA) with a repetition rate of 1.1MHz in or-
dertoachievealongertimewindowfordetectingratherlong
lived Qdot705-STV photoluminescence. The laser was tuned
to 850nm and was frequency doubled to 425nm so that di-
rect excitation of DY731-Bio was kept to a minimum. The
temporalbehaviourofQdot705-STVinadonor-acceptoras-
sembly was investigated with a Hamamatsu C5680 universal
streakcamerasystem(Japan).Thephotoluminescenceofdot
ensemble was spectrally ﬁltered using a 700nm shortpass ﬁl-
ter to cutoﬀunwantedDY731-Bioﬂuorescenceanda630nm
longpass ﬁlter to attenuate any scattered laser. The acquisi-
tion of time-resolved photoluminescence was processed us-
ing high-performance digital temporal analyser (HPD-TA)E. Z. Chong et al. 3
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Figure 2: Normalised absorption and photoluminescence spectra
of Qdot705-STV, DY731-Bio, and DY731-Bio-STV.
software (Hamamatsu, Japan). All measurements were con-
ducted under ambient environmental conditions.
3. RESULTS
3.1. Steady-statespectralmeasurements
3.1.1. Qdot705-STVandDY731-Bio
AsshowninFigure 2,Qdot705-STVsampleexhibitsabroad,
continuous absorption spectrum with no pronounced ex-
citonic peak being resolved. The bulk-like spectrum is due
to the relative large size variation in the Qdot705-STV en-
semble which have a mean diameter of ∼20nm [12]. These
QDs ﬂuoresce at 705nm with a full width at half maxi-
m u m( F W H M )o f7 0 n m( - -i nFigure 2). The FWHM
of Qdot705-STV emission is approximately 3 times broader
than that of the commercial CdSe/ZnS Qdots. The inhomo-
geneous size distribution is likely to be the reason behind the
broad photoluminescence spectrum, however, the crystalline
geometry and the lattice defects can also be the cofactors to
the line width broadening [13].
Unlike Qdot705-STV, pure DY731-Bio have a narrow
absorption spectrum that peaks at 720nm with a weaker
secondary absorption at 660nm. This strongly coincides
with the photoluminescence of Qdot705-STV which spreads
across the absorption band of DY731-Bio. However, the
absorptivity was modiﬁed when DY731-Bio were attached
to streptavidin, as depicted in Figure 2. The 660nm ab-
sorption strength rose above that of 720nm peak. This
is possibly due to the conformational changes in bound
DY731-Bio molecules. The molar extinction coeﬃcients
of DY731-Bio-STV at respective 660nm and 720nm were
found to be 100000M−1cm−1 and 70000M−1cm−1 instead
of 50000M−1cm−1 and 120000M−1cm−1 for pure DY731-
Bio.
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Figure 3: Spectra A are the composite photoluminescence of the
Qdot705-STV and DY731-Bio mixtures in a series of DY731-Bio
titrations. Spectra B are the control photoluminescence of pure
DY731-Bio solutions with the equal molar concentration of DY731
as that in the former mixtures. An expanded view of the control
spectra is shown in the inset.
The strong overlap between the DY731-Bio absorption
and the Qdot705-STV photoluminescence favours the non-
radiative energy transfer within the donor-acceptor assay.
With the large Stokes shift (∼30nm), DY731-Bio are spec-
trally well separated from Qdot705-STV and hence, the
composite photoluminescence spectrum of a mixed donor-
acceptor ensemble can be resolved and deconvoluted into re-
spective spectra for further quantitative FRET analysis.
3.1.2. Qdot705-STVandDY731-Biomixturebytitration
Successivetitrationswith30μMDY731-Biosolutionresulted
in the progressive quenching of Qdot705-STV photolumi-
nescence. Initially, the ﬂuorescence signal at 705nm dropped
abruptlybutthengraduallylevelledoﬀafteratotalof ∼26μL
DY731-Bio have been dispensed into the QD solution. Since
the optical densities in the ﬁrst few titrations (2μL-22μL)
were below 0.2, the luminescence quenching in Qdot705-
STV was primarily attributed to FRET. The reabsorption of
Qdot705-STV photoluminescence by DY731-Bio was antic-
ipated to be less eﬀective. In concomitant with the quench-
ing of Qdot705-STV ﬂuorescence, a systematic enhancement
of DY731-Bio photoluminescence was detected as shown in
Figure 3(A) with the appearance of a 750nm peak. The en-
hanced ﬂuorescence of DY731-Bio in the mixture was many
times more intense than the control signal of pure DY731-
Bio (see the inset of Figure 3) as the absorption of the so-
lution was dominated by the strong optical interaction with
the QD excitons at the excitation wavelength of 425nm. The
quenching of Qdot705-STV emission and the concurrent4 Journal of Biomedicine and Biotechnology
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Figure 4: The scattered plot represents the FRET eﬃciency as a
function of DY731-Bio to Qdot705-STV molar concentration ra-
tio of nonﬁltered mixture. The eﬃciency calculated is based on the
extractedQdot705-STVspectra(fromSpectraAinFigure 3)sho wn
in the inset.
enhancement of DY731-Bio emission signify the occurrence
of FRET from the photoexcited Qdot705-STV donors to the
ground-state DY731-Bio acceptors.
Since FRET theory is formulated based on proximal
dipole-dipole interaction, the excited QDs were generalised
as the oscillating dipoles because of the strong electron-hole
wavefunction overlap in the core and the weak carrier tun-
nelling into the wide band gap ZnS shell [14]. FRET eﬃ-
ciency was calculated in accordance to the following equa-
tion:
E = 1 −
FDA
FD
,( 1 )
where FDA is the integrated donor ﬂuorescence in the pres-
ence of the acceptor and FD is the integrated donor ﬂuo-
rescence alone. As the equation is only dependent upon the
changes of donor emission intensity with acceptor, the rele-
vant Qdot705-STV spectra were extracted from the compos-
ite spectra in Figure 3(A), provided that the spectral shape
ofQdot705-STVstayedunchangedthroughoutthemeasure-
ments. As depicted in Figure 4, despite the undesirable size,
a reasonably high-eﬃcient energy transfer (∼70%) can be
achieved by Qdot705-STV as the FRET donor since its sur-
face area is large enough to interact with multiple DY731-
Bio acceptors. However, the plot of FRET eﬃciency against
acceptor/donor ratio shows some signs of saturation when
the molar ratio exceeded 50 : 1. After the 50 : 1 molar ra-
tio, the incremental step in FRET eﬃciency for successive
DY731-Bio titrations scaled down dramatically. Unlike the
inorganic QD, the conventional organic dyes are generally
conﬁned to single donor-acceptor pairing in a FRET assay
because of their comparatively small molecular sizes, which
in turn impose strict spatial separation condition between
the interacting donor-acceptor molecules (typically less than
100 ˚ A) for achieving high FRET eﬃciency.
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Figure 5: Photoluminescence decay of Qdot705-STV with increas-
ing number of labelled DY731-Bio after centrifugation.
3.2. Temporalphotoluminescencemeasurements
3.2.1. Qdot705-STV-DY731-Bioconjugatesby
ultraﬁltration
Due to the partial crosstalk, the Qdot705-STV emission was
spectrally separated from DY731-Bio using a 700nm short-
pass ﬁlter. By monitoring the temporal changes in the ﬂuo-
rescence spectrum below 700nm, the interaction dynamics
of Qdot705-STV ensembles in the presence of bound accep-
tors were studied. As illustrated in Figure 5, with increasing
number of bound DY731-Bio from 5 to 20 per dot, the QD
ﬂuorescence decay was progressively shortened. Henceforth,
it would appear that an additional nonradiative relaxation
pathway was introduced when DY731-Bio ﬂuorophores were
self-assembled around Qdot705-STV: the photoexcited QD
excitons recombined at a faster rate by coupling to the ra-
diationless transitions. In view of the fact that a Qdot705-
STV can be chemically coupled up to 10 tetrameric strepta-
vidin [12], the highest elicited number of labelled DY731-
Bio per QD from the absorption measurement was relatively
low compared with the prediction that a maximum 40 bi-
otinylated biomolecules can be possibly assembled around a
Qdot705-STV. Therefore, this elucidates, in practise, the av-
eragenumberofstreptavidinperQDmaybelessthan10,and
also the obscuration of some of the binding sites due to the
compactness of large streptavidin proteins around the QD is
not unlikely.
The ﬂuorescence decay curves shown in Figure 5 depict
a complex, multiexponential relaxation of the dots and so a
speciﬁc method of analysis must be adopted in interpreting
the data. We use a biexponential ﬁtting that (i) is the sim-
plest approach outside of a monoexponential model and (ii)
provides a conceptual framework for interpretation relating
to QD photophysics. There are of course alternative mea-
sures that could be adopted, for example, the deﬁnition ofE. Z. Chong et al. 5
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an eﬀective 1/e lifetime. Our main purpose in this paper is to
highlight the complexity of the QD decay dynamics and as-
sesstheramiﬁcationsofthisinquantifyingFRET-basedanal-
yses. The ﬂuorescence dynamic of Qdot705-STV was ﬁtted
with the decay function:
I(t) = A1 exp

−t
τ1

+A2 exp

−t
τ2

+Z (2)
withZ asthebaseline.Twodistinctlifetimecomponentswere
derived from the ﬁt. τ1 fell within 100-nanosecond range
and τ2 fell within 30-nanosecond range. We associate each
lifetime component to diﬀerent, spatially distinct excitonic
relaxation paths [15]. From the two lifetime components,
FRET eﬃciency was explicitly calculated for each dynamic
process using the equation below:
E = 1 −
τDA
τD
,( 3 )
where τDA is the donor ﬂuorescence lifetime in the pres-
ence of the acceptors and τD is the donor ﬂuorescence life-
time without the acceptors. Since FRET is the inverse sixth
power to R (donor-acceptor separation), it is intuitive that
the eﬃciency from spatially separated recombination paths
will diﬀer. As reﬂected in Figure 7, the short-lifetime com-
ponent achieved higher FRET eﬃciency as compared to that
of the long-lifetime component. In this FRET study, we were
abletoobtainanapproximate46%eﬃciencyfromtheshort-
lifetime component at an average 20 bound DY731-Bio per
QD. On the contrary, the eﬃciency was merely 27% for the
long-lifetime component at the same labelling ratio. The
marked variation asserts the close proximity of the fast de-
cay pathway to the DY731-Bio acceptors.
4. DISCUSSION
Qdot705-STV is a core-shell QD coated with a layer of
amphiphilic polymer for water solubility and further sur-
face functionalized with streptavidin for biolinking purposes
[16]. Its core is made of direct gap II-VI CdTe with band gap
energy of 1.44eV (at room temperature) [17] which coarsely
dictates the emission wavelength of QD. By surface passi-
vation with a larger band gap material like ZnS (3.54eV
at room temperature), the quantum yield of the QDs can
be signiﬁcantly enhanced by suppressing the surface states
which may arise from the lattice reconstructions at the ﬁ-
nal stage of nucleation [6, 7, 18]. However, a perfect passi-
vation is diﬃcult to achieve due to appreciable lattice mis-
match between CdTe and ZnS. The lattice constants for CdTe
and ZnS are 4.57 ˚ A and 3.81 ˚ A (wurzite) [17], respectively,
which accounts for a total of 17% diﬀerence in bond length.
IncomparisontothevisibleQDswhicharetypicallymadeof
CdSe, the mismatch is less, at about 12% [6, 19]. So, the sur-
face defects are more predominant in CdTe/ZnS core-shell
QDs. The presence of carrier traps near the CdTe/ZnS in-
terface can weaken the oscillator strength of the dipole mo-
ment by decreasing the spatial overlap of the exciton wave-
function [20]. Photoexcited electrons are quickly delocalized
by surface states, but due to a reduced mobility, the heav-
ier hole is restricted to the inner core. Other factors such as
geometrical characteristics of QD (shape and size) can inﬂu-
e n c et h eo p t i c a la b s o r p t i o na sw e l l[ 13]. Qdot705-STV may
not experience the same quantum conﬁnement eﬀects in all
dimensions like other commercial visible range Qdots (i.e.,
Qdot565 and Qdot585) since it adopts a slightly elongated
geometry which means that the photoinduced carriers have
greater degree of freedom compared to the symmetric spher-
ical QDs [21]. Therefore, the quantization of excited states is
less pronounced in the Qdot705-STV absorption spectrum.
Bacterial derivative streptavidin is known to have excep-
tionally high biotin binding aﬃnity (Ka ≈ 2.5 × 1013 M−1)
[22]. Lower nonspeciﬁc binding as compared to analo-
gous egg white derivative avidin is an added advantage6 Journal of Biomedicine and Biotechnology
in developing superior bioassays for nanosensing devices.
In this work, we study the near-ﬁeld interactions in
Qdot705-STV-DY731-Bio self-assembled assay with the use
of streptavidin-biotin noncovalent linkers. With the capac-
ity of accommodating multiple bioconjugations and the
good spectral overlap between donor emission and accep-
tor absorption, FRET can occur between large QDs and bio-
quenchers [23] .I nt h i sQ DF R E Ti n v e s t i g a t i o n ,w ew e r ea b l e
to achieve high FRET transfer between large Qdot705-STV
and DY731-Bio. Besides that, we also observed some dras-
tic changes in the absorption properties of DY731-Bio when
they were bound to streptavidin. The 660nm absorbance
was much stronger than the absorbance at 720nm. The ﬂu-
orophore probably reoriented itself during the association
of streptavidin-biotin and hence, induced some structural
changes to accommodate the binding site. It is unlikely that
the changes in the absorption were caused by the surface
charge of streptavidin since the same spectral shift was de-
tected when DY731-Bio were dispensed in either ethanol
or PBS solvents. The analytical interpretation of the FRET-
based assay becomes more complicated if the molar extinc-
tion coeﬃcient of the acceptor is undesirably modiﬁed upon
binding. It could possibly inﬂuence the overlap integral J,
F¨ orster distance R0 down to the theoretical FRET eﬃciency
prediction.
Strong enhancement in DY731-Bio emission due to ra-
diationless energy transfer from photoexcited Qdot705-STV
was observed. Direct excitation at 425nm was minimal as
shown in Figure 3(B). In contrast to the DY731-Bio accep-
tor, the photoluminescence of Qdot705-STV was quenched
drastically during the initial stage of titrations when the ma-
jorityoftheaddedDY731-BioshouldhaveattachedontoQD
surface via streptavidin-biotin aﬃnity. Based on the ﬁndings
in Section 3.2, after the centrifugation with a Microcon ﬁl-
ter device, one Qdot705-STV can bind up to 20 biotinylated
acceptors. In regard to that information, for a nonﬁltered so-
lution, further titrations (between ∼20 : 1 and ∼60 : 1 molar
ratio) should only saturate the outermost surface area of the
QDs with free DY731-Bio. As a result, the diﬀused free and
theimmobilisedDY731-BiowerecompetingforFRETwhich
inherentlyledtotheenhancedeﬃciencyafterthemolarratio
of 20 : 1. We speculate that the slow growth in the eﬃciency
after 22μL of DY731-Bio could be the onset of eﬀective ra-
diative quenching by DY731-Bio. It is clear that Qdot705-
S T Vc a ns e r v ea sa ne ﬃcient donor if the interactions with
multiple acceptors are permitted.
The photoluminescence decay of a QD ensemble is mul-
tiexponential. The photophysical characteristics in QD en-
sembles have been correlated to decay-time ﬂuctuations in
single QDs [24, 25]. Since the measurements here were taken
over an extended period of time, the intensity-dependent ef-
fect and the size dispersion in the QD ensemble have aver-
aged out the decay lifetime. The photoluminescence decay
can be considered as the collective dynamic behaviour of ex-
cited QDs. We statistically ﬁtted the Qdot705-STV photolu-
minescence decay with discrete biexponential function. The
ﬁtted lifetimes were signiﬁcantly diﬀerent, 30 nanoseconds
and 100 nanoseconds, respectively. Due to a 17% lattice mis-
match at the core-shell interface, the formation of fast re-
sponse, carrier trapping states at the surface is highly prob-
able. These surface states provide nonradiative relaxation
pathways for the photoinduced electron-hole pairs. Since ex-
citon quenching by surface states usually occurs within sub-
nanosecond times, we attribute the fast decay to carrier trap-
ping by surface states and the slow decay to radiative recom-
bination from the band edge. Besides the QD excitonic state,
surface states can also couple to DY731-Bio excited state
for radiationless energy transfer provided that the surface-
state energy level is within the strong absorption band of
DY731-Bio. Instead of taking the amplitude-weighted mean
lifetime, FRET generated from two separate transitions were
studied independently. From Figure 7, the reduction of the
long-lifetime component was less signiﬁcant than that of the
short-lifetime component with increasing conjugation ratio.
FRET from surface states was apparently more eﬃcient than
thatfromthebandedgelevel.Assumingthatthisisduetothe
R−6 relation of FRET, the results are consistent with the in-
terpretation based on the biexponential decay model that the
surface states are spatially nearer to labelled DY731-Bio and
the band edge recombination primarily occurs within the in-
ner core.
5. CONCLUSIONS
We explored the possibility of FRET in a Qdot705-
STV-DY731-Bio assembly with the application of strong
streptavidin-biotin binding aﬃnity. By careful selection, we
minimized the spectral crosstalk between QD donor and
ﬂuorophore acceptor emissions but maximized the spectral
overlap between donor emission and acceptor absorption.
FRET was derived as the resultant of the quenching eﬀect
onQDsteady-stateﬂuorescenceinstepwiseDY731-Biotitra-
tions. An eﬃciency of ∼70% was easily achieved at a molar
ratio of 50 acceptors to one QD owing to QD’s large sur-
face area. We also recorded the diﬀerences in the absorptiv-
ity between DY731-Bio and DY731-Bio-STV which could be
related to the structural reorientation of ﬂuorophores when
molecular complex was formed. However, no further struc-
tural studies were conducted to examine the conformation
of steptavidin bound DY731-Bio. Any variation in the ab-
sorption strength of conjugated acceptor can render FRET
less eﬃcient than predicted, if it is based on the optical den-
sity of the noninteracting acceptor. By size exclusion ﬁltra-
tion, excess DY731-Bio were removed and only Qdot705-
STV-DY731-Bio were collected. We achieved ∼20 acceptors
per QD which resulted in ∼50% FRET eﬃciency. Lifetime
measurements on the Qdot705-STV-DY731-Bio assay have
further conﬁrmed that FRET can be realized despite the un-
desirable size of QD. However, the highest eﬃciency obtain-
able is limited by the number of streptavidin attached to
Qdot705-STV.
ACKNOWLEDGMENTS
The authors would like to express their gratitude to EPSRC-
GSK for the ﬁnancial support. E. Z. Chong is funded by GSK
underDHPAscheme.TheyalsothankRCUKforthesupport
under the “Optical Biochips” Basic Technology project.E. Z. Chong et al. 7
REFERENCES
[1] R. M. Clegg, “The history of FRET: from conception through
the labors of birth,” in Reviews in Fluorescence,J .R .L a k o w i c z
and C. D. Geddes, Eds., vol. 3, pp. 1–45, Springer, New York,
NY, USA, 2006.
[2] J .R.Lakowicz,PrinciplesofFluorescenceSpectroscopy,Springer,
Berlin, Germany, 2006.
[3] I. Z. Steinberg, “Long-range nonradiative transfer of elec-
tronic excitation energy in proteins and polypeptides,” Annual
Review of Biochemistry, vol. 40, pp. 83–114, 1971.
[4] L. Stryer, “Fluorescence energy transfer as a spectroscopic
ruler,” Annual Review of Biochemistry, vol. 47, pp. 819–846,
1978.
[5] P.G.WuandL.Brand,“Resonanceenergy-transfer—methods
and applications,” Analytical Biochemistry, vol. 218, no. 1, pp.
1–13, 1994.
[6] M. A. Hines and P. Guyot-Sionnest, “Synthesis and character-
ization of strongly luminescing ZnS-capped CdSe nanocrys-
tals,” Journal of Physical Chemistry, vol. 100, no. 2, pp. 468–
471, 1996.
[7] B. O. Dabbousi, J. Rodriguez-Viejo, F. V. Mikulec, et al.,
“(CdSe)ZnS core-shell quantum dots: Synthesis and charac-
terization of a size series of highly luminescent nanocrystal-
lites,” Journal of Physical Chemistry B, vol. 101, no. 46, pp.
9463–9475, 1997.
[8] X.Peng,M.C.Schlamp,A.V.Kadavanich,andA.P.Alivisatos,
“Epitaxial growth of highly luminescent CdSe/CdS core/shell
nanocrystals with photostability and electronic accessibility,”
Journal of the American Chemical Society, vol. 119, no. 30, pp.
7019–7029, 1997.
[9] W.J.Parak,T.Pellegrino,andC.Plank,“Labellingofcellswith
quantum dots,” Nanotechnology, vol. 16, no. 2, pp. R9–R25,
2005.
[10] D. M. Willard, L. L. Carillo, J. Jung, and A. Van Orden, “CdSe-
ZnS quantum dots as resonance energy transfer donors in
a model protein-protein binding assay,” Nano Letters, vol. 1,
no. 9, pp. 469–474, 2001.
[11] E. Oh, M. Y. Hong, D. Lee, S. H. Nam, H. C. Yoon, and H. S.
Kim, “Inhibition assay of biomolecules based on ﬂuorescence
resonance energy transfer (FRET) between quantum dots and
gold nanoparticles,” Journal of the American Chemical Society,
vol. 127, no. 10, pp. 3270–3271, 2005.
[12] Invitrogen, “Qdot streptavidin conjugates user manual,” 2006.
[13] A. P. Alivisatos, “Perspectives on the physical chemistry of
semiconductor nanocrystals,” Journal of Physical Chemistry,
vol. 100, no. 31, pp. 13226–13239, 1996.
[14] A. R. Clapp, I. L. Medintz, and H. Mattoussi, “F¨ orster reso-
nance energy transfer investigations using quantum-dot ﬂuo-
rophores,” ChemPhysChem, vol. 7, no. 1, pp. 47–57, 2006.
[15] L.A.Padilha,A.A.-R.Neves,C.L.Cesar,L.C.Barbosa,andC.
H. Brito-Cruz, “Recombination processes in CdTe quantum-
dot-doped glasses,” Applied Physics Letters, vol. 85, no. 15, pp.
3256–3258, 2004.
[ 1 6 ]X .Y .W u ,H .J .L i u ,J .Q .L i u ,e ta l . ,“ I m m u n o ﬂ u o r e s c e n tl a -
beling of cancer marker Her2 and other cellular targets with
semiconductor quantum dots,” Nature Biotechnology, vol. 21,
no. 1, pp. 41–46, 2003.
[17] D. R. Lide, Ed., CRC Handbook of Chemistry and Physics,C R C
Press, Boca Raton, FL, USA, 2001.
[18] A. P. Alivisatos, “Semiconductor clusters, nanocrystals, and
quantum dots,” Science, vol. 271, no. 5251, pp. 933–937, 1996.
[19] M. Nirmal and L. Brus, “Luminescence photophysics in
semiconductor nanocrystals,” Accounts of Chemical Research,
vol. 32, no. 5, pp. 407–414, 1999.
[20] Y. Wang and N. Herron, “Nanometer-sized semiconductor
clusters: materials synthesis, quantum size eﬀects, and pho-
tophysical properties,” Journal of Physical Chemistry, vol. 95,
no. 2, pp. 525–532, 1991.
[21] B. N.-G. Giepmans, T. J. Deerinck, B. L. Smarr, Y. Z. Jones,
and M. H. Ellisman, “Correlated light and electron micro-
scopic imaging of multiple endogenous proteins using Quan-
tum dots,” Nature Methods, vol. 2, no. 10, pp. 743–749, 2005.
[22] A. Chilkoti and P. S. Stayton, “Molecular origins of the slow
streptavidin-biotin dissociation kinetics,” Journal of the Amer-
ican Chemical Society, vol. 117, no. 43, pp. 10622–10628, 1995.
[23] A. R. Clapp, I. L. Medintz, J. M. Mauro, B. R. Fisher, M. G.
Bawendi, and H. Mattoussi, “Fluorescence resonance energy
transferbetweenquantumdotdonorsanddye-labeledprotein
acceptors,” Journal of the American Chemical Society, vol. 126,
no. 1, pp. 301–310, 2004.
[24] G. Schlegel, J. Bohnenberger, I. Potapova, and A. Mews, “Flu-
orescence decay time of single semiconductor nanocrystals,”
Physical Review Letters, vol. 88, no. 13, pp. 1374011–1374014,
2002.
[25] B. R. Fisher, H.-J. Eisler, N. E. Stott, and M. G. Bawendi,
“Emission intensity dependence and single-exponential be-
havior in single colloidal quantum dot ﬂuorescence lifetimes,”
Journal of Physical Chemistry B, vol. 108, no. 1, pp. 143–148,
2004.